Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Besmir Nreu

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 30, 2020
Factors associated with increased all-cause mortality during the COVID-19 pandemic in ItalyEdoardo Mannucci, Besmir Nreu, Matteo Monami
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2019
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trialsEdoardo Mannucci, Ilaria Dicembrini, Besmir Nreu, et al.
Diabetes, Obesity & Metabolism|April 12, 2019
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trialsIlaria Dicembrini, Besmir Nreu, Edoardo Mannucci, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trialsEdoardo Mannucci, Ilaria Dicembrini, Besmir Nreu, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 5, 2022
Covid-19 pandemic, diabetes and glycemic control: Results of a retrospective cohort study of 230.000 persons with diabetes in tuscanyBenedetta Bellini, Besmir Nreu, Paolo Francesconi, et al.
Diabetes, Obesity & Metabolism|January 13, 2018
Short and medium-term efficacy of sodium glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized clinical trialsMatteo Monami, Francesco Liistro, Alessia Scatena, et al.
Diabetes Research and Clinical Practice|August 12, 2019
Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trialsClaudia Cosentino, Ilaria Dicembrini, Besmir Nreu, et al.
Acta Diabetologica|January 20, 2020
Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trialsIlaria Dicembrini, Besmir Nreu, Chiara Montereggi, et al.
Minerva Endocrinology|July 29, 2020
Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trialsBesmir Nreu, Ilaria Dicembrini, Federico Tinti, et al.
International Journal of Endocrinology|October 9, 2015
Effects of a Short Educational Program for the Prevention of Foot Ulcers in High-Risk Patients: A Randomized Controlled TrialMatteo Monami, Stefania Zannoni, Marianna Gaias, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 30, 2020
Factors associated with increased all-cause mortality during the COVID-19 pandemic in ItalyEdoardo Mannucci, Besmir Nreu, Matteo Monami
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2019
Exploring the heterogeneity of the effects of SGLT-2 inhibitors in cardiovascular outcome trialsEdoardo Mannucci, Ilaria Dicembrini, Besmir Nreu, et al.
Diabetes, Obesity & Metabolism|April 12, 2019
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trialsIlaria Dicembrini, Besmir Nreu, Edoardo Mannucci, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trialsEdoardo Mannucci, Ilaria Dicembrini, Besmir Nreu, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 5, 2022
Covid-19 pandemic, diabetes and glycemic control: Results of a retrospective cohort study of 230.000 persons with diabetes in tuscanyBenedetta Bellini, Besmir Nreu, Paolo Francesconi, et al.
Diabetes, Obesity & Metabolism|January 13, 2018
Short and medium-term efficacy of sodium glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized clinical trialsMatteo Monami, Francesco Liistro, Alessia Scatena, et al.
Diabetes Research and Clinical Practice|August 12, 2019
Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trialsClaudia Cosentino, Ilaria Dicembrini, Besmir Nreu, et al.
Acta Diabetologica|January 20, 2020
Risk of cancer in patients treated with dipeptidyl peptidase-4 inhibitors: an extensive meta-analysis of randomized controlled trialsIlaria Dicembrini, Besmir Nreu, Chiara Montereggi, et al.
Minerva Endocrinology|July 29, 2020
Pancreatitis and pancreatic cancer in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trialsBesmir Nreu, Ilaria Dicembrini, Federico Tinti, et al.
International Journal of Endocrinology|October 9, 2015
Effects of a Short Educational Program for the Prevention of Foot Ulcers in High-Risk Patients: A Randomized Controlled TrialMatteo Monami, Stefania Zannoni, Marianna Gaias, et al.
Pageof 3